Frailty in Patients With Lung Cancer : A Systematic Review and Meta-Analysis
Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved..
BACKGROUND: Previous studies regarding the prevalence of frailty in patients with lung cancer and mortality in frail patients with lung cancer are inconsistent and require clarification.
RESEARCH QUESTION: What is the prevalence and impact of frailty in patients with lung cancer?.
STUDY DESIGN AND METHODS: This systematic review and meta-analysis used a combination of free-text terms and medical subject headings terms, according to the database requirements in MEDLINE/PubMed, Scopus, and Cochrane Library from inception until November 15, 2020.
RESULTS: A total of 2,571 articles were identified, and 16 articles involving 4,183 patients were included for study. The prevalence of frailty in lung cancer was 45% (95% CI, 28-61; I2 = 99.5%; P < .0001). In patients with lung cancer, frailty was associated with an increased hazard ratio for mortality (hazard ratio, 3.01; 95% CI, 1.77-5.10; P < .001).
INTERPRETATION: The prevalence of frailty in lung cancer is 45%, which has a significant negative impact on survival of patients with lung cancer. These results highlight the importance of measuring frailty, which provides important prognostic information, and may provide opportunities for interventions to improve outcomes in patients with lung cancer.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:162 |
|---|---|
| Enthalten in: |
Chest - 162(2022), 2 vom: 01. Aug., Seite 485-497 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Komici, Klara [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Elderly |
|---|
| Anmerkungen: |
Date Completed 10.08.2022 Date Revised 22.03.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.chest.2022.02.027 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM337485097 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM337485097 | ||
| 003 | DE-627 | ||
| 005 | 20231225234519.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.chest.2022.02.027 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1124.xml |
| 035 | |a (DE-627)NLM337485097 | ||
| 035 | |a (NLM)35217002 | ||
| 035 | |a (PII)S0012-3692(22)00391-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Komici, Klara |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Frailty in Patients With Lung Cancer |b A Systematic Review and Meta-Analysis |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 10.08.2022 | ||
| 500 | |a Date Revised 22.03.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a BACKGROUND: Previous studies regarding the prevalence of frailty in patients with lung cancer and mortality in frail patients with lung cancer are inconsistent and require clarification | ||
| 520 | |a RESEARCH QUESTION: What is the prevalence and impact of frailty in patients with lung cancer? | ||
| 520 | |a STUDY DESIGN AND METHODS: This systematic review and meta-analysis used a combination of free-text terms and medical subject headings terms, according to the database requirements in MEDLINE/PubMed, Scopus, and Cochrane Library from inception until November 15, 2020 | ||
| 520 | |a RESULTS: A total of 2,571 articles were identified, and 16 articles involving 4,183 patients were included for study. The prevalence of frailty in lung cancer was 45% (95% CI, 28-61; I2 = 99.5%; P < .0001). In patients with lung cancer, frailty was associated with an increased hazard ratio for mortality (hazard ratio, 3.01; 95% CI, 1.77-5.10; P < .001) | ||
| 520 | |a INTERPRETATION: The prevalence of frailty in lung cancer is 45%, which has a significant negative impact on survival of patients with lung cancer. These results highlight the importance of measuring frailty, which provides important prognostic information, and may provide opportunities for interventions to improve outcomes in patients with lung cancer | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a elderly | |
| 650 | 4 | |a frailty | |
| 650 | 4 | |a lung cancer | |
| 650 | 4 | |a mortality | |
| 650 | 4 | |a outcome | |
| 700 | 1 | |a Bencivenga, Leonardo |e verfasserin |4 aut | |
| 700 | 1 | |a Navani, Neal |e verfasserin |4 aut | |
| 700 | 1 | |a D'Agnano, Vito |e verfasserin |4 aut | |
| 700 | 1 | |a Guerra, Germano |e verfasserin |4 aut | |
| 700 | 1 | |a Bianco, Andrea |e verfasserin |4 aut | |
| 700 | 1 | |a Rengo, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Perrotta, Fabio |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Chest |d 1970 |g 162(2022), 2 vom: 01. Aug., Seite 485-497 |w (DE-627)NLM000002720 |x 1931-3543 |7 nnns |
| 773 | 1 | 8 | |g volume:162 |g year:2022 |g number:2 |g day:01 |g month:08 |g pages:485-497 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.chest.2022.02.027 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 162 |j 2022 |e 2 |b 01 |c 08 |h 485-497 | ||